Proactive Investors - Run By Investors For Investors

Sativa Investments inks commercial offtake agreement with Portuguese cannabis oil supplier

Sativa Investments said the offtake agreement will provide clarity to a major part of the supply chain and give consistency across quality and pricing
cannabis
The deal is subject to regulatory approval in Portugal

Sativa Investments PLC (NEX:SATI) has inked a commercial offtake agreement with Portuguese cannabis oil supplier, MeridianTulip – Empresa Medicinal Lda, for the UK manufacture of cannabidiol (CBD) products.

Under the deal, the UK medicinal cannabis company will acquire low tetrahydrocannabinol (THC) cannabis oil for the UK manufacturer of CBD products at its Somerset headquarters.

READ: Medicinal cannabis investor Sativa Investments turns maiden gross profit

THC is a compound in the cannabis plant that gives the “high” associated with recreational use while CBD is non-psychoactive. Medicinal cannabis, which was legalised in the UK late last year, contains CBD and low levels of THC.

Sativa plans to supply the cannabis products to its subsidiary George Botanicals, a manufacturer, wholesaler and retailer of CBD wellness products. It will also supply to Sativa’s Goodbody & Blunt wellness centres, which is to open its first store, in Bath, soon.  

The offtake agreement is subject to MeridianTulip receiving authority from Portuguese regulatory authority, Infarmed, for the cultivation and export of medicinal cannabis.

Sativa said Infarmed has granted two such licences to date and the company is confident Meridian’s discussions are “progressing well”.

“The offtake agreement with Meridian, once it receives its Infarmed licence, will provide clarity to a major part of the supply chain and give consistency across quality and pricing, as well as allowing the company to determine exact seed strains and growing conditions,” said Sativa founder and chief executive, Geremy Thomas.

“Yet again Sativa is at the forefront of this industry by identifying smart-sourcing as preferable to growing, as the company concentrates on the value-add elements of the industry, including research & development, manufacturing, brands, and distribution." 

View full SATI profile View Profile

Sativa Investments Timeline

Related Articles

cancer scan
January 03 2019
The company, which owns a piece of software which predicts the effects of drugs on cancers, has recently extended a lucrative agreement with German firm Merck Serono while it has also signed a strategic collaboration with the Medicines Discovery Catapult
man pointing to brain
April 25 2019
Brain Scientific’s EEG technology is far cheaper and less bulky than a traditional EEG system, but provides EEG tracings of the same quality
Sativa
June 07 2019
Geremy Thomas, founder and chief executive of Sativa, said the company has "delivered expeditiously on its investment promise to the market"

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use